Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Sarah B. Mulkey's research focuses on neurological and developmental outcomes in infants and children, with a particular emphasis on conditions arising from prenatal exposures and infections. Her work investigates the long-term neurodevelopmental consequences of in utero exposure to viruses such as Zika and SARS-CoV-2, examining potential links to birth defects and cognitive outcomes. Mulkey also studies neonatal encephalopathy, exploring its epidemiology and etiology, and has contributed to refining consensus definitions and subclassification of hypoxic-ischemic encephalopathy.
Her research extends to the impact of medical interventions on neurodevelopment, including investigations into transfusions and their effects on extremely low gestation neonates. Mulkey has also analyzed outcomes for conditions diagnosed prenatally, such as agenesis of the corpus callosum. With a substantial publication record (140 publications, 3,062 citations) and an h-index of 30, she is recognized as a highly cited researcher. She leads an active research group and collaborates with other researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Metrics
- h-index: 30
- Publications: 140
- Citations: 3,102
Selected Publications
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns (2022)
Collaboration Network
Top Collaborators
- Outcome of Agenesis of the Corpus Callosum Diagnosed by Fetal MRI
- Autonomic development in preterm infants is associated with morbidity of prematurity
- The Role of Fetal MRI for Suspected Anomalies of the Posterior Fossa
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Taenia–tela choroidea complex and choroid plexus location help distinguish Dandy-Walker malformation and Blake pouch cysts
Showing 5 of 9 shared publications
- Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses
- Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Outcomes up to age 36 months after congenital Zika virus infection—U.S. states
- Congenital infectious encephalopathies from the intrapartum period to postnatal life
Showing 5 of 9 shared publications
- Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Neurodevelopmental Outcomes of Preschoolers with Antenatal Zika Virus Exposure Born in the United States
- Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure
- School-age child neurodevelopment following antenatal Zika virus exposure
Showing 5 of 8 shared publications
- Outcome of Agenesis of the Corpus Callosum Diagnosed by Fetal MRI
- Autonomic development in preterm infants is associated with morbidity of prematurity
- The Role of Fetal MRI for Suspected Anomalies of the Posterior Fossa
- Taenia–tela choroidea complex and choroid plexus location help distinguish Dandy-Walker malformation and Blake pouch cysts
- In infants with congenital heart disease autonomic dysfunction is associated with pre-operative brain injury
Showing 5 of 7 shared publications
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Neurodevelopmental Outcomes of Preschoolers with Antenatal Zika Virus Exposure Born in the United States
- Harnessing the power of telemedicine to accomplish international pediatric outcome research during the COVID-19 pandemic
- Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure
Showing 5 of 7 shared publications
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort
Showing 5 of 6 shared publications
- Autonomic development in preterm infants is associated with morbidity of prematurity
- In infants with congenital heart disease autonomic dysfunction is associated with pre-operative brain injury
- Cerebral cortical autonomic connectivity in low-risk term newborns
- Electroencephalogram in low-risk term newborns predicts neurodevelopmental metrics at age two years
- Functional brain network properties of healthy full-term newborns quantified by scalp and source-reconstructed EEG
Showing 5 of 6 shared publications
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Neurodevelopmental Outcomes of Preschoolers with Antenatal Zika Virus Exposure Born in the United States
- Harnessing the power of telemedicine to accomplish international pediatric outcome research during the COVID-19 pandemic
- Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure
Showing 5 of 6 shared publications
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Neurodevelopmental Outcomes of Preschoolers with Antenatal Zika Virus Exposure Born in the United States
- Harnessing the power of telemedicine to accomplish international pediatric outcome research during the COVID-19 pandemic
- Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure
Showing 5 of 6 shared publications
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Harnessing the power of telemedicine to accomplish international pediatric outcome research during the COVID-19 pandemic
- Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure
- School-age child neurodevelopment following antenatal Zika virus exposure
Showing 5 of 6 shared publications
- Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome
- Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry
- Neurodevelopmental Outcomes of Preschoolers with Antenatal Zika Virus Exposure Born in the United States
- School-age child neurodevelopment following antenatal Zika virus exposure
- Positive and negative effects of the COVID‐19 pandemic on families of young children in rural Colombia and implications for child outcome research
Showing 5 of 6 shared publications
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
- Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Similar Researchers
Based on overlapping research topics